Results 201 to 210 of about 31,418 (244)
Landscape of clinical trials in cancer cachexia: assessment of trends from 1995-2024. [PDF]
BMC CancerCabrera AR +4 more
europepmc +1 more source
Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia. [PDF]
Nat MetabAngelino E +29 more
europepmc +1 more source
Implementation and Feasibility of a Multidisciplinary Endocrine-Led Outpatient Clinic for Cancer Cachexia and Other Forms of Unintentional Weight Loss: A Real-World Observational Study. [PDF]
Cancers (Basel)Murthy A +5 more
europepmc +1 more source
CircAMOTL1 promotes adipose lipolysis and browning in cancer cachexia through miR-211-5p-mediated TET2 activation. [PDF]
J Biol ChemDing Z +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2018
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation.
Vickie E, Baracos +4 more
exaly +6 more sources
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation.
Vickie E, Baracos +4 more
exaly +6 more sources
Clinical Journal of Oncology Nursing
Cancer cachexia is characterized by metabolic dysregulation, inflammation, and reduced food intake, and it results in loss of skeletal muscle. Although cachexia is pervasive in patients with advanced cancer, comprehensive cac.
Michael S Yule +3 more
+7 more sources
Cancer cachexia is characterized by metabolic dysregulation, inflammation, and reduced food intake, and it results in loss of skeletal muscle. Although cachexia is pervasive in patients with advanced cancer, comprehensive cac.
Michael S Yule +3 more
+7 more sources
International Journal of Oncology, 1997
Cancer cachexia is a complex syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia and asthenia. The complications associated with the appearance of the cachectic syndrome affect both the physiological and biochemical balance of the patient, and have effects on the efficiency of the ...
J, Argiles, F, Lopezsoriano
openaire +2 more sources
Cancer cachexia is a complex syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia and asthenia. The complications associated with the appearance of the cachectic syndrome affect both the physiological and biochemical balance of the patient, and have effects on the efficiency of the ...
J, Argiles, F, Lopezsoriano
openaire +2 more sources
International journal of pancreatology, 1990
Cancer cachexia has been listed as a major cause of death in cancer patients. In order to investigate the metabolic effects of the tumor on the host, we have evaluated an experimental model of cancer cachexia in the mouse (MAC16 colon adenocarcinoma), in which weight loss can reach 30-40% of initial weight with a tumor burden of only 2.5%, without a ...
M J, Tisdale, S A, Beck
openaire +2 more sources
Cancer cachexia has been listed as a major cause of death in cancer patients. In order to investigate the metabolic effects of the tumor on the host, we have evaluated an experimental model of cancer cachexia in the mouse (MAC16 colon adenocarcinoma), in which weight loss can reach 30-40% of initial weight with a tumor burden of only 2.5%, without a ...
M J, Tisdale, S A, Beck
openaire +2 more sources